Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TCann is an Australian medicinal cannabis and novel medicines company operating as a licensed manufacturer, wholesaler, and contract manufacturing partner. The business was founded in 2017 to improve access to medical cannabis in Australia and has since built GMP-accredited manufacturing capabilities in New South Wales. TCann provides end-to-end services spanning supply chain management, importation, testing, packaging, relabelling, extraction, and finished product manufacturing for medicinal cannabis products and related pharmaceutical customers. Publicly available materials emphasize commercial manufacturing and distribution rather than a traditional disclosed therapeutic pipeline, positioning the company more as an operating medicinal-cannabis manufacturer/CDMO than a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TCann.